Aug 2026· Current Opinion in Chemical Biology· Vol 94, pp.
102752
· 0 citations· 51 references
Medicine
TL;DR
This review summarizes major advances in enzyme discovery in plant natural product biosynthesis in recent years, focusing on emerging catalytic mechanisms, strategies for elucidating pathways, and evolutionary relationships, and highlights their implications for synthetic biology, metabolic engineering, and the sustainable production of valuable natural products.
Abstract
Plants are a vast reservoir of natural products with diverse structural scaffolds, making them an invaluable source for discovering novel enzymes that catalyze unique and evolutionarily specialized metabolic transformations in biosynthetic pathways. Rapid advances in genomics, metabolomics, protein structure prediction, and heterologous pathway reconstruction have enabled the identification of numerous cryptic biosynthetic enzymes responsible for key scaffold-forming and tailoring reactions in metabolism. Particularly notable are the discoveries of plant-derived enzymes that catalyze challenging chemical transformations, including oxidative carbon-carbon bond rearrangements, atypical cycloadditions, radical-mediated coupling reactions, and iterative scaffold remodeling. This review summarizes major advances in enzyme discovery in plant natural product biosynthesis in recent years, focusing on emerging catalytic mechanisms, strategies for elucidating pathways, and evolutionary relationships, and highlights their implications for synthetic biology, metabolic engineering, and the sustainable production of valuable natural products.
This article systematically reviews the latest progress in the biosynthesis of plant natural products, focusing on the synthesis pathways of key compounds such as terpenoids and alkaloids, as well as the strategies for constructing microbial factories and the key challenges of heterologous products.
This review addresses the central question of how biosynthetic precision and chemical diversification can be coupled when conventional metabolic engineering alone cannot fully overcome low titers, enzyme promiscuity limits, intermediate toxicity, and scale-up heterogeneity.
Sha Liu, Pan Chen, Hai-Tao Li et al.· Frontiers in Microbiology· 0 citations
The findings affirm that CRISPR is reshaping the landscape of plant biotechnology, offering sustainable routes for producing high-value metabolites for food, medicine and industry.
Sravanthi Pammi S.S.· Research journal of biotechn...· 0 citations
Current strategies for marine natural product discovery are summarized and emerging translational approaches integrating multi-omics technologies, pathway engineering, and AI-guided prioritization are highlighted, providing a roadmap for advancing marine Streptomyces research from descriptive omics-based exploration to...
M. Lertcanawanichakul, P. Bhoopong, Tuanhawanti Sahabuddeen et al.· Marine Drugs· 0 citations
Tryptophan-derived metabolites are indole-containing compounds with applications in medicine, functional foods, and agriculture. Conventional production via plant extraction or chemical synthesis is often inefficient and unsustainable, prompting the development of microbial biosynthesis. In this review, these metabolit...
Chen-Xi Qiu, Hong-Wei Guo, Quan-Pu Ren et al.· Journal of Agricultural and...· 0 citations
Terpenoid indole alkaloids (TIAs) are a class of structurally diverse natural products with important pharmacological activities. Recently, substantial progress has been made in elucidating TIA biosynthetic pathways, and these studies have revealed the central roles of CYP71 clan enzymes (CYP71s) in both the formatio...
Jia-Xin Gao, Hong-Hao Li, Yun-Zi Luo· Chem & Bio Engineering· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.